福耀(03606.HK)续涨17%创逾两年半高 季绩胜预期获多间大行升价
福耀玻璃(03606.HK)第三季业绩胜预期,多间大行绩後上调福耀评级及目标价,其中摩通上调评级至「增持」及目标价升至38元;瑞银及花旗分别升价至40.6元及34元,重申「买入」评级。该股承过去三连涨势,今早股价逼近2018年1月所创上市高位35元,最高见34.25元,现造33.5元,急涨17%,成交急增至1,045万股,为近4年最多,涉资3.43亿元。
福耀昨天收市公布,今年首三季纯利按年跌26.6%至17.23亿人民币,总营收按年跌近12%至137.76亿元人民币。单计第三季纯利按年减近9.8%至7.59亿人民币,营收56.55亿元人民币,按年升5.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.